发明名称 Specific determination of NCA 90 glycoform in the blood of cancer patients
摘要 <p>It has been found that although both glycoforms of the cancer marker NCA 50/90 are expressed in normal tissue, only the 90 kDa glycoform is secreted into the bloodstream. An improved method is therefore provided for aiding in the diagnosis of, and monitoring the progression or course of cancer, particularly breast, colon, and lung cancer, and leukemia, in a patient by measuring the amount of NCA 90 specifically in a blood sample, e.g., serum sample, obtained from the patient.</p>
申请公布号 EP0747705(A1) 申请公布日期 1996.12.11
申请号 EP19960108409 申请日期 1996.05.28
申请人 BAYER CORPORATION 发明人 VERY, DONALD L.;YEUNG, KWOK K.;ALLARD, WILLIAM JEFFREY
分类号 G01N33/574;G01N33/577;(IPC1-7):G01N33/574 主分类号 G01N33/574
代理机构 代理人
主权项
地址
您可能感兴趣的专利